The global intravenous (IV) therapy and vein access market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing number of patients suffering from chronic diseases such as diabetes, cancer, and cardiovascular diseases. These patients require IV therapy for long-term treatment which in turn increases the demand for IV therapy devices.
The global intravenous (IV) therapy and vein access market has been segmented on the basis of type into infusion pumps, implantable ports, intravenous catheters, and hypodermic needles; by application into hospital and clinics; by region into North America, Latin America, Europe, Asia Pacific & Middle East & Africa; and by country into US, Canada, Mexico Brazil Russia China India Japan South Korea Australia New Zealand Saudi Arabia UAE Qatar Kuwait Oman Bahrain Iran Iraq Israel Jordan Lebanon Syria Yemen Egypt Libya Algeria Tunisia Morocco Nigeria Kenya Sudan Ghana Ethiopia Kenya Uganda Tanzania Rwanda Zambia Malawi Mozambique Zimbabwe Madagascar Mauritius Comoros Seychelles Djibouti Eritrea Somalia Ethiopia Sudan Chad Niger Nigeria Cameroon Central African Republic Congo Democratic Republic Of Congo Equatorial Guinea Gabon Sao Tome And Principe Angola Botswana Lesotho Swaziland Namibia Mozambique Madagascar Mauritius Comoros Seychelles Djibouti Eritrea Somalia Ethiopia Sudan Chad Niger Nigeria Cameroon Central African Republic Congo Democratic Republic Of Congo Equatorial Guinea Gabon Sao Tome And Principe Angola Botswana Lesotho Swaziland Namibia.
- The global Intravenous (IV) Therapy and Vein Access market is driven by factors such as increasing prevalence of chronic diseases, rising geriatric population, and growing demand for minimally invasive procedures in developed countries.
- Increasing prevalence of chronic diseases such as diabetes mellitus type 2, cancer, cardiovascular disease, and respiratory disease are driving the growth of the global Intravenous (IV) Therapy and Vein Access market.
- Rising geriatric population in developing countries is also driving the growth of the global Intravenous (IV) Therapy and Vein Access market.
- Growing demand for minimally invasive procedures in developed countries is also driving the growth of the global Intravenous (IV) Therapy and Vein Access market.
Industry Growth Insights published a new data on “Intravenous (IV) Therapy and Vein Access Market”. The research report is titled “Intravenous (IV) Therapy and Vein Access Market research by Types (Infusion pumps, Implantable Ports, Intravenous Catheters, Hypodermic Needles, Other), By Applications (Hospital, Clinics, Other), By Players/Companies B. Braun, Baxter International, Becton Dickinson, C. R. Bard, Fresenius Kabi, Hospira(ICU Medical), Medtronic, Smiths Group, Teleflex”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Intravenous (IV) Therapy and Vein Access Market Research Report
By Type
Infusion pumps, Implantable Ports, Intravenous Catheters, Hypodermic Needles, Other
By Application
Hospital, Clinics, Other
By Companies
B. Braun, Baxter International, Becton Dickinson, C. R. Bard, Fresenius Kabi, Hospira(ICU Medical), Medtronic, Smiths Group, Teleflex
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
 Therapy and Vein Access Industry Outlook.svg)
Global Intravenous (IV) Therapy and Vein Access Market Report Segments:
The global Intravenous (IV) Therapy and Vein Access market is segmented on the basis of:
Types
Infusion pumps, Implantable Ports, Intravenous Catheters, Hypodermic Needles, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinics, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- B. Braun
- Baxter International
- Becton Dickinson
- C. R. Bard
- Fresenius Kabi
- Hospira(ICU Medical)
- Medtronic
- Smiths Group
- Teleflex
 Therapy and Vein Access Market Overview.svg)
Highlights of The Intravenous (IV) Therapy and Vein Access Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Infusion pumps
- Implantable Ports
- Intravenous Catheters
- Hypodermic Needles
- Other
- By Application:
- Hospital
- Clinics
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Intravenous (IV) Therapy and Vein Access Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Therapy and Vein Access Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Intravenous (IV) therapy is a medical procedure in which fluids and medications are delivered directly into the bloodstream through a vein. Vein access refers to the placement of an IV tube in a vein near the surface of the skin.
Some of the key players operating in the intravenous (iv) therapy and vein access market are B. Braun, Baxter International, Becton Dickinson, C. R. Bard, Fresenius Kabi, Hospira(ICU Medical), Medtronic, Smiths Group, Teleflex.
The intravenous (iv) therapy and vein access market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Intravenous (IV) Therapy and Vein Access Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Intravenous (IV) Therapy and Vein Access Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Intravenous (IV) Therapy and Vein Access Market - Supply Chain
4.5. Global Intravenous (IV) Therapy and Vein Access Market Forecast
4.5.1. Intravenous (IV) Therapy and Vein Access Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Intravenous (IV) Therapy and Vein Access Market Size (000 Units) and Y-o-Y Growth
4.5.3. Intravenous (IV) Therapy and Vein Access Market Absolute $ Opportunity
5. Global Intravenous (IV) Therapy and Vein Access Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Intravenous (IV) Therapy and Vein Access Market Size and Volume Forecast by Type
5.3.1. Infusion pumps
5.3.2. Implantable Ports
5.3.3. Intravenous Catheters
5.3.4. Hypodermic Needles
5.3.5. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Intravenous (IV) Therapy and Vein Access Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Intravenous (IV) Therapy and Vein Access Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinics
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Intravenous (IV) Therapy and Vein Access Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Intravenous (IV) Therapy and Vein Access Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Intravenous (IV) Therapy and Vein Access Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Intravenous (IV) Therapy and Vein Access Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Intravenous (IV) Therapy and Vein Access Demand Share Forecast, 2019-2026
9. North America Intravenous (IV) Therapy and Vein Access Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Intravenous (IV) Therapy and Vein Access Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Intravenous (IV) Therapy and Vein Access Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinics
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Intravenous (IV) Therapy and Vein Access Market Size and Volume Forecast by Type
9.7.1. Infusion pumps
9.7.2. Implantable Ports
9.7.3. Intravenous Catheters
9.7.4. Hypodermic Needles
9.7.5. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Intravenous (IV) Therapy and Vein Access Demand Share Forecast, 2019-2026
10. Latin America Intravenous (IV) Therapy and Vein Access Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Intravenous (IV) Therapy and Vein Access Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Intravenous (IV) Therapy and Vein Access Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinics
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Intravenous (IV) Therapy and Vein Access Market Size and Volume Forecast by Type
10.7.1. Infusion pumps
10.7.2. Implantable Ports
10.7.3. Intravenous Catheters
10.7.4. Hypodermic Needles
10.7.5. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Intravenous (IV) Therapy and Vein Access Demand Share Forecast, 2019-2026
11. Europe Intravenous (IV) Therapy and Vein Access Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Intravenous (IV) Therapy and Vein Access Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Intravenous (IV) Therapy and Vein Access Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinics
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Intravenous (IV) Therapy and Vein Access Market Size and Volume Forecast by Type
11.7.1. Infusionpumps
11.7.2. Implantable Ports
11.7.3. Intravenous Catheters
11.7.4. Hypodermic Needles
11.7.5. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Intravenous (IV) Therapy and Vein Access Demand Share, 2019-2026
12. Asia Pacific Intravenous (IV) Therapy and Vein Access Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Intravenous (IV) Therapy and Vein Access Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Intravenous (IV) Therapy and Vein Access Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinics
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Intravenous (IV) Therapy and Vein Access Market Size and Volume Forecast by Type
12.7.1. Infusion pumps
12.7.2. Implantable Ports
12.7.3. Intravenous Catheters
12.7.4. Hypodermic Needles
12.7.5. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Intravenous (IV) Therapy and Vein Access Demand Share, 2019-2026
13. Middle East & Africa Intravenous (IV) Therapy and Vein Access Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Intravenous (IV) Therapy and Vein Access Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Intravenous (IV) Therapy and Vein Access Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinics
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Intravenous (IV) Therapy and Vein Access Market Size and Volume Forecast by Type
13.7.1. Infusion pumps
13.7.2. Implantable Ports
13.7.3. Intravenous Catheters
13.7.4. Hypodermic Needles
13.7.5. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Intravenous (IV) Therapy and Vein Access Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Intravenous (IV) Therapy and Vein Access Market: Market Share Analysis
14.2. Intravenous (IV) Therapy and Vein Access Distributors and Customers
14.3. Intravenous (IV) Therapy and Vein Access Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. B. Braun
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Baxter International
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Becton Dickinson
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. C. R. Bard
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Fresenius Kabi
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Hospira(ICU Medical)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Medtronic
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Smiths Group
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Teleflex
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
